182 related articles for article (PubMed ID: 38702792)
1. The deubiquitinase USP7 and E3 ligase TRIM21 regulate vasculogenic mimicry and malignant progression of RMS by balancing SNAI2 homeostasis.
Zhang R; Zhang D; Han F; Song X; Zhang Y; Zhang J; Zhu Q; Qin Y
J Exp Clin Cancer Res; 2024 May; 43(1):135. PubMed ID: 38702792
[TBL] [Abstract][Full Text] [Related]
2. A complex of the ubiquitin ligase TRIM32 and the deubiquitinase USP7 balances the level of c-Myc ubiquitination and thereby determines neural stem cell fate specification.
Nicklas S; Hillje AL; Okawa S; Rudolph IM; Collmann FM; van Wuellen T; Del Sol A; Schwamborn JC
Cell Death Differ; 2019 Mar; 26(4):728-740. PubMed ID: 29899379
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
4. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
[TBL] [Abstract][Full Text] [Related]
5. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination of p21 by E3 Ligase TRIM21 Promotes the Proliferation of Human Neuroblastoma Cells.
Wang F; Wu Z; Li Q; Ni Z; Wang C; Lu J
Neuromolecular Med; 2021 Dec; 23(4):549-560. PubMed ID: 33900537
[TBL] [Abstract][Full Text] [Related]
7. METTL3-mediated HOTAIRM1 promotes vasculogenic mimicry icontributionsn glioma via regulating IGFBP2 expression.
Wu Z; Wei N
J Transl Med; 2023 Nov; 21(1):855. PubMed ID: 38012763
[TBL] [Abstract][Full Text] [Related]
8. A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis.
Zhang Q; Cao C; Gong W; Bao K; Wang Q; Wang Y; Bi L; Ma S; Zhao J; Liu L; Tian S; Zhang K; Yang J; Yao Z; Song N; Shi L
Theranostics; 2020; 10(23):10769-10790. PubMed ID: 32929379
[No Abstract] [Full Text] [Related]
9. Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.
Li J; Zhang B; Feng Z; An D; Zhou Z; Wan C; Hu Y; Sun Y; Wang Y; Liu X; Wei W; Yang X; Meng J; Che M; Sheng Y; Wu B; Wen L; Huang F; Li Y; Yang K
J Exp Clin Cancer Res; 2024 Jan; 43(1):28. PubMed ID: 38254206
[TBL] [Abstract][Full Text] [Related]
10. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
[TBL] [Abstract][Full Text] [Related]
12. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
13. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer.
Zhao J; Wu J; Qin Y; Zhang W; Huang G; Qin L
Cell Oncol (Dordr); 2020 Oct; 43(5):863-876. PubMed ID: 32729021
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits.
Mitxitorena I; Somma D; Mitchell JP; Lepistö M; Tyrchan C; Smith EL; Kiely PA; Walden H; Keeshan K; Carmody RJ
J Biol Chem; 2020 Aug; 295(33):11754-11763. PubMed ID: 32587091
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitylation and stabilization of ARMC5 by ubiquitin-specific processing protease 7 (USP7) are critical for RCC proliferation.
Yan G; Liu N; Tian J; Fu Y; Wei W; Zou J; Li S; Wang Q; Li K; Wang J
J Cell Mol Med; 2021 Mar; 25(6):3149-3159. PubMed ID: 33544460
[TBL] [Abstract][Full Text] [Related]
18. ASB13 inhibits breast cancer metastasis through promoting SNAI2 degradation and relieving its transcriptional repression of YAP.
Fan H; Wang X; Li W; Shen M; Wei Y; Zheng H; Kang Y
Genes Dev; 2020 Oct; 34(19-20):1359-1372. PubMed ID: 32943576
[TBL] [Abstract][Full Text] [Related]
19. USP7 promotes non-small-cell lung cancer cell glycolysis and survival by stabilizing and activating c-Abl.
He Y; Jiang S; Zhong Y; Wang X; Cui Y; Liang J; Sun Y; Zhu Z; Huang Z; Mao X
Clin Transl Med; 2023 Dec; 13(12):e1509. PubMed ID: 38082439
[TBL] [Abstract][Full Text] [Related]
20. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
